...While it’s good that people are resuming their regular visits, the data suggest people haven’t been making up for the missed screens earlier in the pandemic, said Ahmedin Jemal, senior vice president of surveillance and health equity science at the American Cancer Society and the senior author on the study.
A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.
For older Americans, the pandemic still poses significant dangers. About three-quarters of Covid deaths have occurred in people over 65, with the greatest losses concentrated among those over 75.
Recent Comments